Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07482475 · ClinicalTrials.gov registry record
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
A clinical trial of Smoking, Cigarette and COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of Michigan.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07482475: Recruiting study of Smoking, Cigarette and COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of Michigan.
NCT07482475 is a study of Smoking, Cigarette and COPD (Chronic Obstructive Pulmonary Disease) that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 200 participants, below the 524-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07482475, a study of Smoking, Cigarette and COPD (Chronic Obstructive Pulmonary Disease), is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to obtain new knowledge regarding screening for COPD. This study will use a participant's cancer screening CT scans performed as part of routine health care among current and former smokers at risk for COPD to identify participants who have had a spirometry or will have a spirometry test as part of the study to verify COPD status.
Primary Outcome
All participants in this study must have had a previous lung cancer screening CT scan as part of their normal medical care within one year of enrolling in this study. These pre-enrollment scans will be evaluated to determine how many scans that had been intended to identify lung cancer also indicate COPD.
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-07-15 |
| Est. Completion | 2026-12 |
What NCT07482475 shows while recruiting
NCT07482475 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 524-participant average among 21 other Smoking, Cigarette trials with a reported enrollment target (62% lower).
The record links to 3 conditions, with Smoking, Cigarette appearing as the primary indexed condition, and to 0 interventions.
NCT07482475 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07482475 about?
NCT07482475 is a clinical study titled "University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2". The purpose of this study is to obtain new knowledge regarding screening for COPD. This study will use a participant's cancer screening CT scans performed as part of routine health care among current and former smokers at risk for COPD to identify participants who have had a spirometry or will have ...
What is the current status of trial NCT07482475?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-07-15. Estimated completion is 2026-12.
What conditions does trial NCT07482475 study?
This clinical trial studies the following conditions: Smoking, Cigarette, COPD (Chronic Obstructive Pulmonary Disease), Cancer Lung Screening.
Who is sponsoring clinical trial NCT07482475?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07482475 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking, Cigarette
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07482475's enrollment target sits among peer trials
200 8th of 21 higher than 14 of 21 other Smoking, Cigarette trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking, Cigarette trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
RECRUITING
-
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
RECRUITING · Phase 1
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
RECRUITING · NA
-
Optimizing Tobacco Treatment Delivery for People Living With HIV
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI